TABLE OF CONTENTS
1 INTRODUCTION 47
1.1 OBJECTIVES OF THE STUDY 47
1.2 MARKET DEFINITION 47
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET 47
1.4 LIMITATIONS 49
1.5 MARKETS COVERED 49
2 MARKET SEGMENTATION 52
2.1 MARKETS COVERED 52
2.2 GEOGRAPHICAL SCOPE 53
2.3 YEARS CONSIDERED FOR THE STUDY 54
2.4 CURRENCY AND PRICING 54
2.5 DBMR TRIPOD DATA VALIDATION MODEL 55
2.6 MULTIVARIATE MODELLING 58
2.7 PRODUCT TYPE LIFELINE CURVE 58
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 59
2.9 DBMR MARKET POSITION GRID 60
2.10 MARKET APPLICATION COVERAGE GRID 61
2.11 VENDOR SHARE ANALYSIS 62
2.12 SECONDARY SOURCES 63
2.13 ASSUMPTIONS 63
3 EXECUTIVE SUMMARY 64
4 PREMIUM INSIGHTS 67
4.1 PESTEL ANALYSIS 68
4.2 PORTER'S FIVE FORCES MODEL 69
4.3 NUMBER OF HOSPITALS ANALYSIS: MIDDLE EAST & AFRICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET 70
4.4 PATENT ANALYSIS OF MIDDLE EAST & AFRICA ELECTROMAGNETIC TRACKING SYSTEMS 71
5 VALUE CHAIN ANALYSIS: MIDDLE EAST & AFRICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET 73
6 INDUSTRY INSIGHTS FOR MIDDLE EAST & AFRICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET 74
6.1 KEY PRICING STRATEGIES 74
6.1.1 PRODUCT INNOVATION 74
6.1.2 CONSUMER AWARENESS 74
6.1.3 A VAST NETWORK OF DISTRIBUTION 75
6.1.4 PARTNERSHIP BY MAJOR PLAYERS 75
6.1.5 IDENTIFICATION OF CUSTOMERS NEED FOR INNOVATIVE PRODUCTS 75
6.1.6 INCREASING SPECIFIC TACTICS FOR EVERY STEP 76
6.1.7 OTHERS 76
6.2 INTERVIEWS WITH MEDICAL DEVICES COMPANIES 76
6.3 INTERVIEWS WITH PHYSICIANS 77
6.4 INTERVIEWS WITH RESEARCH SCHOLAR 77
7 MIDDLE EAST & AFRICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET: REGULATIONS 79
8 MARKET OVERVIEW 83
8.1 DRIVERS 85
8.1.1 RISE IN DEMAND FOR VIRTUAL AND AUGMENTED REALITY TECHNOLOGY 85
8.1.2 GROWING USE OF ELECTROMAGNETIC TRACKING IN AEROSPACE AND DEFENSE 85
8.1.3 RISE IN COLLABORATION AND AGREEMENT OF ELECTROMAGNETIC TRACKING SYSTEMS MARKET PLAYERS WITH HOSPITALS AND OTHER MEDICAL SETTINGS 86
8.1.4 INCREASING DEMAND FOR ELECTROMAGNETIC SURGICAL NAVIGATION 87
8.2 RESTRAINTS 87
8.2.1 STRICT REGULATORY FRAMEWORKS 87
8.2.2 RISK ASSOCIATED WITH HIGH-DOSE RADIATION EXPOSURE 88
8.2.3 HIGH COMPETITION AMONG KEY PLAYERS 88
8.3 OPPORTUNITIES 89
8.3.1 INCREASING APPLICATION OF ELECTROMAGNETIC TRACKING SYSTEMS IN HEALTHCARE 89
8.3.2 GROWING INVESTMENT BY THE GOVERNMENT AND PRIVATE SECTOR 89
8.3.3 ADVANCEMENT IN THE MANUFACTURING INDUSTRY 90
8.4 CHALLENGES 91
8.4.1 HIGH COST OF SYSTEMS 91
8.4.2 ERRORS ASSOCIATED WITH THE INTERFERENCE DURING THE USE OF AN ELECTROMAGNETIC TRACKING SYSTEM 91
9 MIDDLE EAST & AFRICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET, BY PRODUCT TYPE 92
9.1 OVERVIEW 93
9.2 ORTHOPEDIC TRACKING SYSTEM 96
9.2.1 IMAGELESS ORTHOPEDIC SYSTEMS 97
9.2.2 RADIOGRAPHY ORTHOPEDIC SYSTEMS 97
9.2.3 CT-BASED ORTHOPEDIC SYSTEMS 97
9.2.4 FLUOROSCOPY-BASED NAVIGATION SYSTEMS 97
9.3 ENT TRACKING SYSTEM 97
9.3.1 OPTICAL SYSTEM 99
9.3.2 ELECTROMAGNETIC SYSTEM 99
9.3.3 HYBRID SYSTEM 99
9.4 CARDIAC TRACKING SYSTEMS 99
9.5 ELECTROPHYSIOLOGY TRACKING SYSTEMS 100
9.6 NEURONAVIGATION TRACKING SYSTEMS 101
9.6.1 OPTICAL SYSTEM 102
9.6.2 ELECTROMAGNETIC SYSTEM 102
9.7 DENTAL TRACKING SYSTEMS 102
9.8 OTHER SYSTEMS 103
10 MIDDLE EAST & AFRICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET, BY TECHNOLOGY 105
10.1 OVERVIEW 106
10.2 OPTICAL NAVIGATION SYSTEMS 109
10.3 ELECTROMAGNETIC (EM) NAVIGATION SYSTEMS 109
10.4 HYBRID NAVIGATION SYSTEMS 110
10.5 FLUOROSCOPY BASED NAVIGATION SYSTEM 111
10.6 OTHERS 112
11 MIDDLE EAST & AFRICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET, BY CONNECTIVITY 113
11.1 OVERVIEW 114
11.2 WIRED SYSTEMS 117
11.3 WIRELESS SYSTEMS 118
12 MIDDLE EAST & AFRICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET, BY MANEUVERABILITY 119
12.1 OVERVIEW 120
12.2 6-DOF 123
12.3 5-DOF 123
12.4 OTHERS 124
13 MIDDLE EAST & AFRICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET, BY END USER 125
13.1 OVERVIEW 126
13.2 HEALTHCARE FACILITIES 129
13.2.1 HOSPITALS 130
13.2.2 AMBULATORY SERVICE CENTERS 130
13.2.3 RESEARCH/ ACADEMIC INSTITUTIONS 130
13.3 MILITARY AND DEFENCE 130
13.4 INDUSTRIAL AUTOMATION 131
13.5 OTHERS 132
13.5.1 GAMING 133
13.5.2 MEDIA/PRODUCTION 133
13.5.3 SIMULATION AND TRAINING 133
13.5.4 OTHERS 134
14 MIDDLE EAST & AFRICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET, BY APPLICATION 135
14.1 OVERVIEW 136
14.2 ORTHOPEDIC TRACKING SYSTEM 139
14.2.1 DIAGNOSTIC 140
14.2.2 INTERVENTIONAL 140
14.3 ENT TRACKING SYSTEM 140
14.3.1 DIAGNOSTIC 141
14.3.2 INTERVENTIONAL 141
14.4 CARDIAC TRACKING SYSTEMS 141
14.4.1 DIAGNOSTIC 142
14.4.2 INTERVENTIONAL 143
14.5 ELECTROPHYSIOLOGY TRACKING SYSTEMS 143
14.5.1 DIAGNOSTIC 144
14.5.2 INTERVENTIONAL 144
14.6 NEURONAVIGATION TRACKING SYSTEMS 144
14.6.1 DIAGNOSTIC 145
14.6.2 INTERVENTIONAL 145
14.7 DENTAL TRACKING SYSTEMS 145
14.7.1 DIAGNOSTIC 146
14.7.2 INTERVENTIONAL 146
14.8 OTHER SYSTEMS 147
15 MIDDLE EAST & AFRICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET, BY DISTRIBUTION CHANNEL 148
15.1 OVERVIEW 149
15.2 DIRECT TENDER 152
15.3 RETAIL SALES 152
15.4 ONLINE SALES 153
16 MIDDLE EAST & AFRICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET, BY REGION 154
16.1 MIDDLE EAST AND AFRICA 155
16.1.1 SOUTH AFRICA 165
16.1.2 SAUDI ARABIA 170
16.1.3 U.A.E 175
16.1.4 EGYPT 180
16.1.5 ISRAEL 185
16.1.6 REST OF MIDDLE EAST AND AFRICA 190
17 MIDDLE EAST & AFRICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET, COMPANY LANDSCAPE 191
17.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 191
18 SWOT ANALYSIS 192
19 COMPANY PROFILE 193
19.1 TT ELECTRONICS 193
19.1.1 COMPANY SNAPSHOT 193
19.1.2 REVENUE ANALYSIS 193
19.1.3 COMPANY SHARE ANALYSIS 194
19.1.4 PRODUCT PORTFOLIO 194
19.1.5 RECENT DEVELOPMENT 194
19.2 NORTHERN DIGITAL INC 195
19.2.1 COMPANY SNAPSHOT 195
19.2.2 COMPANY SHARE ANALYSIS 195
19.2.3 PRODUCT PORTFOLIO 196
19.2.4 RECENT DEVELOPMENT 196
19.3 AMFITECH APS 197
19.3.1 COMPANY SNAPSHOT 197
19.3.2 COMPANY SHARE ANALYSIS 197
19.3.3 PRODUCT PORTFOLIO 198
19.3.4 RECENT DEVELOPMENT 198
19.4 RADWAVE TECHNOLOGIES INC. 199
19.4.1 COMPANY SNAPSHOT 199
19.4.2 COMPANY SHARE ANALYSIS 199
19.4.3 PRODUCT PORTFOLIO 200
19.4.4 RECENT DEVELOPMENT 200
19.5 OMMO TECHNOLOGIES 201
19.5.1 COMPANY SNAPSHOT 201
19.5.2 COMPANY SHARE ANALYSIS 201
19.5.3 PRODUCT PORTFOLIO 202
19.5.4 RECENT DEVELOPMENTS 202
19.6 POLHEMUS. 203
19.6.1 COMPANY SNAPSHOT 203
19.6.2 PRODUCT PORTFOLIO 203
19.6.3 RECENT DEVELOPMENTS 203
19.7 AUGMEDICS 204
19.7.1 COMPANY SNAPSHOT 204
19.7.2 PRODUCT PORTFOLIO 204
19.7.3 RECENT DEVELOPMENTS 204
19.8 B.BRAUN MELSUNGEN AG 205
19.8.1 COMPANY SNAPSHOT 205
19.8.2 REVENUE ANALYSIS 205
19.8.3 PRODUCT PORTFOLIO 206
19.8.4 RECENT DEVELOPMENT 206
19.9 BRAINLAB AG 207
19.9.1 COMPANY SNAPSHOT 207
19.9.2 PRODUCT PORTFOLIO 207
19.9.3 RECENT DEVELOPMENTS 207
19.10 CIRCINUS MEDICAL TECHNOLOGY. 208
19.10.1 COMPANY SNAPSHOT 208
19.10.2 PRODUCT PORTFOLIO 208
19.10.3 RECENT DEVELOPMENTS 208
19.11 ERGOSURG GMBH 209
19.11.1 COMPANY SNAPSHOT 209
19.11.2 PRODUCT PORTFOLIO 209
19.11.3 RECENT DEVELOPMENTS 209
19.12 FIAGON GMBH 210
19.12.1 COMPANY SNAPSHOT 210
19.12.2 PRODUCT PORTFOLIO 210
19.12.3 RECENT DEVELOPMENTS 210
19.13 HEAL FORCE 211
19.13.1 COMPANY SNAPSHOT 211
19.13.2 PRODUCT PORTFOLIO 211
19.13.3 RECENT DEVELOPMENTS 211
19.14 KARL STORZ SE & CO. KG. 212
19.14.1 COMPANY SNAPSHOT 212
19.14.2 PRODUCT PORTFOLIO 212
19.14.3 RECENT DEVELOPMENTS 212
19.15 KONINKLIJKE PHILIPS N.V. 213
19.15.1 COMPANY SNAPSHOT 213
19.15.2 REVENUE ANALYSIS 213
19.15.3 PRODUCT PORTFOLIO 214
19.15.4 RECENT DEVELOPMENT 214
19.16 MEDACTA INTERNATIONAL 215
19.16.1 COMPANY SNAPSHOT 215
19.16.2 REVENUE ANALYSIS 215
19.16.3 PRODUCT PORTFOLIO 216
19.16.4 RECENT DEVELOPMENT 216
19.17 MEDICAL DEVICE BUSINESS SERVICES, INC. 217
19.17.1 COMPANY SNAPSHOT 217
19.17.2 PRODUCT PORTFOLIO 217
19.17.3 RECENT DEVELOPMENTS 217
19.18 MEDTRONIC 218
19.18.1 COMPANY SNAPSHOT 218
19.18.2 REVENUE ANALYSIS 218
19.18.3 PRODUCT PORTFOLIO 219
19.18.4 RECENT DEVELOPMENT 219
19.19 ORTHALIGN 220
19.19.1 COMPANY SNAPSHOT 220
19.19.2 PRODUCT PORTFOLIO 220
19.19.3 RECENT DEVELOPMENT 220
19.20 SIEMENS AG 221
19.20.1 COMPANY SNAPSHOT 221
19.20.2 REVENUE ANALYSIS 221
19.20.3 PRODUCT PORTFOLIO 222
19.20.4 RECENT DEVELOPMENT 222

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.